These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 30142917

  • 21. Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1.
    Duan L, Perez RE, Hansen M, Gitelis S, Maki CG.
    Cancer Biol Ther; 2014; 15(12):1600-12. PubMed ID: 25482935
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Normal p53 status and function despite the development of drug resistance in human breast cancer cells.
    Wosikowski K, Regis JT, Robey RW, Alvarez M, Buters JT, Gudas JM, Bates SE.
    Cell Growth Differ; 1995 Nov; 6(11):1395-403. PubMed ID: 8562478
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness.
    Pavan S, Olivero M, Corà D, Di Renzo MF.
    Eur J Cancer; 2013 Mar; 49(4):964-73. PubMed ID: 23079474
    [Abstract] [Full Text] [Related]

  • 31. Phosphorylated Hsp27 activates ATM-dependent p53 signaling and mediates the resistance of MCF-7 cells to doxorubicin-induced apoptosis.
    Xu Y, Diao Y, Qi S, Pan X, Wang Q, Xin Y, Cao X, Ruan J, Zhao Z, Luo L, Liu C, Yin Z.
    Cell Signal; 2013 May; 25(5):1176-85. PubMed ID: 23357534
    [Abstract] [Full Text] [Related]

  • 32. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline.
    Fan S, Smith ML, Rivet DJ, Duba D, Zhan Q, Kohn KW, Fornace AJ, O'Connor PM.
    Cancer Res; 1995 Apr 15; 55(8):1649-54. PubMed ID: 7712469
    [Abstract] [Full Text] [Related]

  • 33. Emodin induces a reactive oxygen species-dependent and ATM-p53-Bax mediated cytotoxicity in lung cancer cells.
    Lai JM, Chang JT, Wen CL, Hsu SL.
    Eur J Pharmacol; 2009 Nov 25; 623(1-3):1-9. PubMed ID: 19744477
    [Abstract] [Full Text] [Related]

  • 34. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P, Giarola M, Righetti SC, Supino R, Caserini C, Delia D, Pierotti MA, Miyashita T, Reed JC, Zunino F.
    Cancer Res; 1996 Feb 01; 56(3):556-62. PubMed ID: 8564971
    [Abstract] [Full Text] [Related]

  • 35. Cisplatin overcomes Bcl-2-mediated resistance to apoptosis via preferential engagement of Bak: critical role of Noxa-mediated lipid peroxidation.
    Kutuk O, Arisan ED, Tezil T, Shoshan MC, Basaga H.
    Carcinogenesis; 2009 Sep 01; 30(9):1517-27. PubMed ID: 19578044
    [Abstract] [Full Text] [Related]

  • 36. The association between p53 protein phosphorylation at serine 15, serine 20 and sensitivity of cells isolated from patients with ovarian cancer and cell lines to chemotherapy in in vitro study.
    Kamińska I, Bar JK.
    Pharmacol Rep; 2018 Jun 01; 70(3):570-576. PubMed ID: 29684847
    [Abstract] [Full Text] [Related]

  • 37. Regulation of p53 target gene expression by cisplatin-induced extracellular signal-regulated kinase.
    DeHaan RD, Yazlovitskaya EM, Persons DL.
    Cancer Chemother Pharmacol; 2001 Nov 01; 48(5):383-8. PubMed ID: 11761456
    [Abstract] [Full Text] [Related]

  • 38. Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells.
    Yang H, He L, Kruk P, Nicosia SV, Cheng JQ.
    Int J Cancer; 2006 Nov 15; 119(10):2304-12. PubMed ID: 16894566
    [Abstract] [Full Text] [Related]

  • 39. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells.
    Matsumoto M, Nakajima W, Seike M, Gemma A, Tanaka N.
    Biochem Biophys Res Commun; 2016 Apr 29; 473(2):490-6. PubMed ID: 26996126
    [Abstract] [Full Text] [Related]

  • 40. CDDP induces p53-dependent apoptosis in tongue cancer cells.
    Kanata H, Yane K, Ota I, Miyahara H, Matsunaga T, Takahashi A, Ohnishi K, Ohnishi T, Hosoi H.
    Int J Oncol; 2000 Sep 29; 17(3):513-7. PubMed ID: 10938392
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.